Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04368364 · ClinicalTrials.gov registry record · Phase 4
A Randomized Control Trial Comparing Analgesic Benefits of Ultrasound-guided Single vs Continuous Quadratus Lumborum Blocks (QLB)vs Intrathecal Morphine(ITM) for Post Cesarean Section Pain
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT04368364 is a Phase 4 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 3 participants.
The verdict
NCT04368364, a Phase 4 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
the purpose of this study is to compare opioid consumption in morphine equivalents between the groups that received postoperative analgesia with intrathecal morphine versus US guided QL blocks versus US guided QL catheters
Interventions
- DRUG Bupivacaine hydrochloride
- DRUG ropivacaine hydrochloride
- DRUG Intrathecal morphine sulfate (ITM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-05-22 |
| Est. Completion | 2020-06-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04368364
The ClinicalTrials.gov registry entry for NCT04368364 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bupivacaine hydrochloride is the first listed.
NCT04368364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04368364 about?
NCT04368364 is a clinical study titled "A Randomized Control Trial Comparing Analgesic Benefits of Ultrasound-guided Single vs Continuous Quadratus Lumborum Blocks (QLB)vs Intrathecal Morphine(ITM) for Post Cesarean Section Pain". the purpose of this study is to compare opioid consumption in morphine equivalents between the groups that received postoperative analgesia with intrathecal morphine versus US guided QL blocks versus US guided QL catheters
What is the current status of trial NCT04368364?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2020-05-22. Estimated completion is 2020-06-29.
What interventions are being tested in trial NCT04368364?
The interventions under investigation include: Bupivacaine hydrochloride (DRUG), ropivacaine hydrochloride (DRUG), Intrathecal morphine sulfate (ITM) (DRUG).
Who is sponsoring clinical trial NCT04368364?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.